The Supreme Court ruled that stem cell therapy cannot be offered as a clinical treatment for autism. The Court said there is no scientific evidence proving its efficacy or safety, making informed consent impossible.
Hearing a petition on unregulated promotion of “miracle cures,” the Court criticized the Centre for failing to take action against individuals and clinics offering stem cell therapy for autism. It said vulnerable patients and their families are at risk of exploitation.
The bench directed that only approved clinical trials under strict regulatory supervision can explore stem cell research. It called for a dedicated regulatory body to oversee stem cell therapies and research in India, ensuring ethical and scientific standards are met.
The Court emphasized that unverified therapies should not be marketed or offered to the public. Doctors and clinics promoting such treatments could face legal action.
Stem cell therapy cannot be offered as a clinical service for autism, the Supreme Court noted, reinforcing that patient safety and scientific validation must guide medical practices. It also urged public awareness campaigns to prevent misinformation about unproven treatments.
